Researchers Identify Endocannabinoid Signaling as a Pharmaceutical Target for Obesity

News   Jan 12, 2017 | Original Source From University of California Riverside

 
Researchers Identify Endocannabinoid Signaling as a Pharmaceutical Target for Obesity
 
 
 

RELATED ARTICLES

Revealing How Dietary Fat Affects Stem Cell Differentiation

News

A recent study suggests a general mechanism by which dietary fats affect cellular physiology through remodeling of membrane lipidomes, biophysical properties and signaling.

READ MORE

The Lipid Data Analyzer: Deciphering Lipid Structure

News

For the detection of lipids indicative for diseases, healthy and sick organisms are typically compared quantitatively. This comparison requires reliable and detailed information about the structure and composition of lipids from tissue samples - and to this end researchers from the BioTechMed-Graz initiative have developed a tool which is presented in the current issue of Nature Methods.

READ MORE

Boost for Lipid Research: Researchers Facilitate Lipid Data Analysis

News

Illnesses such as cancer and multiple sclerosis may also be associated with lipids. Disorders are difficult to assess due to the diversity of lipids. Scientists present a new tool for the analysis of lipids.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE